Notwithstanding these inadequacies, we still demonstrate that endothelial cells-derived FGF2 plays an important part in promoting docetaxel resistance of prostate cancer cells through in vitro and in vivo experiments. This evidence concerns the gene FGF2 and Familial prostate cancer.